Measurement of a novel biomarker, secretory phospholipase A2 group IIA as a marker of sepsis: A pilot study

Abstract

sPLA2-IIA shows potential as a biomarker distinguishing sepsis from other disease entities. Further study is warranted to identify predictive value of trends in sPLA-IIA during disease course in septic patients.